While GSCs were enriched for IFITM3, GSC serum-differentiated cells (GSDCs) exhibited reduced expression (Fig. 2D), indicating that IFITM3 was solely expressed in neural stem cells or cancer stem cells. This evidence concerns the gene IFITM3 and cancer.